Categories : Oncology
Product Packaging : 1 Vial
Product Composition : 3.5 mg
Bortezomib for Injection is a highly effective proteasome inhibitor anticancer (targeted therapy) formulation used primarily in the treatment of multiple myeloma and mantle cell lymphoma. Bortezomib works by inhibiting the 26S proteasome, leading to disruption of protein degradation in cancer cells, ultimately causing apoptosis and inhibition of tumor growth.
This formulation is typically available as a lyophilized powder for reconstitution, ensuring optimal stability and potency before administration. It is widely used in oncology and hematology settings as part of advanced targeted therapy regimens.
Manufactured under stringent sterile and oncology-grade conditions, Bortezomib for Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent efficacy. As a trusted Bortezomib Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label solutions, and global bulk supply.
Send MessageBortezomib for Injection is a highly effective proteasome inhibitor anticancer (targeted therapy) formulation used primarily in the treatment of multiple myeloma and mantle cell lymphoma. Bortezomib works by inhibiting the 26S proteasome, leading to disruption of protein degradation in cancer cells, ultimately causing apoptosis and inhibition of tumor growth.
This formulation is typically available as a lyophilized powder for reconstitution, ensuring optimal stability and potency before administration. It is widely used in oncology and hematology settings as part of advanced targeted therapy regimens.
Manufactured under stringent sterile and oncology-grade conditions, Bortezomib for Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent efficacy. As a trusted Bortezomib Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label solutions, and global bulk supply.
Bortezomib for Injection is commonly used in the treatment of:
This targeted oncology injection is administered under strict medical supervision in oncology and hematology settings.
Lyophilized injectable dosage form offers key advantages:
